PBH FY 2016 Earnings Report — Prestige Consumer Healthcare Inc. Revenue & Financial Results | Market Cap Arena

Prestige Consumer Healthcare Inc.PBH

FY 2016 Earnings

Reported May 17, 2016

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2016	Prior Q	FY 2015	QoQ Change	YoY Change
Revenue	$806M	—	$715M	—	12.8%
Op. Income	$260M	—	$208M	—	25.4%
Gross Margin	57.9%	—	56.8%	—	1.1pp
Net Margin	12.4%	—	11.0%	—	1.4pp
EPS (Diluted)	$1.88	—	$1.49	—	26.2%
Free Cash Flow	$171M	—	$150M	—	13.7%

Revenue Flow

Item	Amount
REVENUE	$806M
Cost of Revenue	$339M
GROSS PROFIT	$467M
R&D Expenses	$0
Selling & Marketing	$111M
General & Administrative	$72M
SG&A Expenses	$183M
Other Expenses	$24M
Operating Expenses	$207M
Cost & Expenses	$546M
OPERATING INCOME	$260M
Interest Income	$162.0K
Interest Expense	$85M
Other Income/Expenses	-$103M
INCOME BEFORE TAX	$157M
Income Tax Expense	$57M
Net Income from Continuing Ops	$100M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$100M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$100M
D&A	$24M
EBIT	$243M
EBITDA	$266M
EPS	$2
EPS Diluted	$2

Income Statement

Item	Amount
REVENUE	$806M
Cost of Revenue	$339M
GROSS PROFIT	$467M
R&D Expenses	$0
Selling & Marketing	$111M
General & Administrative	$72M
SG&A Expenses	$183M
Other Expenses	$24M
Operating Expenses	$207M
Cost & Expenses	$546M
OPERATING INCOME	$260M
Interest Income	$162.0K
Interest Expense	$85M
Other Income/Expenses	-$103M
INCOME BEFORE TAX	$157M
Income Tax Expense	$57M
Net Income from Continuing Ops	$100M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$100M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$100M
D&A	$24M
EBIT	$243M
EBITDA	$266M
EPS	$2
EPS Diluted	$2

Cash Flow Statement

Item	Amount
Net Income	$100M
Depreciation & Amortization	$24M
Stock-Based Compensation	$10M
Deferred Income Tax	$46M
Other Non-Cash Items	$16M
Change in Working Capital	-$22M
OPERATING CASH FLOW	$174M
Capital Expenditure	-$4M
Acquisitions (Net)	-$227M
Purchases of Investments	$0
Sales/Maturities of Investments	$0
Other Investing Activities	$8M
NET CASH FROM INVESTING	-$223M
Net Debt Issuance	$59M
Common Stock Repurchased	-$2M
Common Dividends Paid	$0
Other Financing Activities	-$12M
NET CASH FROM FINANCING	$54M
FREE CASH FLOW	$171M
Net Change in Cash	$6M

Balance Sheet

Item	Amount
Cash & Equivalents	$27M
Short-Term Investments	$0
Net Receivables	$95M
Inventory	$91M
Other Current Assets	$10M
TOTAL CURRENT ASSETS	$249M
PP&E (Net)	$16M
Goodwill	$360M
Intangible Assets	$2.3B
Long-Term Investments	-$10M
Tax Assets	$10M
Other Non-Current Assets	$1M
TOTAL NON-CURRENT ASSETS	$2.7B
TOTAL ASSETS	$2.9B
Account Payables	$38M
Short-Term Debt	$0
Deferred Revenue	$0
Other Current Liabilities	$11M
TOTAL CURRENT LIABILITIES	$107M
Long-Term Debt	$1.6B
Deferred Revenue NC	$0
Deferred Tax Liabilities	$470M
Other Non-Current Liabilities	$3M
TOTAL NON-CURRENT LIABILITIES	$2.1B
TOTAL LIABILITIES	$2.2B
Common Stock	$530.0K
Additional Paid-In Capital	$445M
Retained Earnings	$327M
Treasury Stock	-$5M
Accum. Other Comp. Income	-$24M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$744M
Minority Interest	$0
TOTAL EQUITY	$744M
TOTAL LIABILITIES & EQUITY	$2.9B
Total Debt	$1.6B
Net Debt	$1.6B